Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.

Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.

http://www.wikidata.org/entity/Q30619473

about

Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses Epidemiology and prevention of stroke: a worldwide perspective Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients Using benefit-based tailored treatment to improve the use of antihypertensive medications.The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients Preventing the progression of prehypertension to hypertension: role of antihypertensives.Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.Pre-hypertension: another 'pseudodisease'?The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.Increasing prevalence of lifestyle diseases: high time for action.The burden of non-adherence to cardiovascular medications among the aging population in Australia: a meta-analysis.Treatment of risk factors to prevent stroke.Autonomic and hemodynamic origins of pre-hypertension: central role of heredity.Proof of concept in cardiovascular risk: the paradoxical findings in blood pressure and lipid abnormalities Blood pressure and TNF-α act synergistically to increase leucocyte CD11b adhesion molecule expression in the BELFAST study: implications for better blood pressure control in ageing.Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life.Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.7th Brazilian Guideline of Arterial Hypertension: Chapter 5 - Therapeutic Decision and Targets I Brazilian position paper on prehypertension, white coat hypertension and masked hypertension: diagnosis and management.What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?The cardiovascular polypill in high-risk patients.Current challenges in the clinical management of hypertension.Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.Are there new threshold and goals in the treatment of arterial hypertension?Heart failure in hypertension: prevention and treatment.Can the effectiveness of hypertension management be improved?Blood pressure targets in the treatment of high blood pressure: a reappraisal of the J-shaped phenomenon.Pre-hypertension: rationale for pharmacotherapy.Prehypertension--prevalence, health risks, and management strategies.Advances in stroke prevention.Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.The J-curve Association between Systolic Blood Pressure and Clinical Outcomes in Ischemic Stroke or TIA: The BOSS Study.RESPONSE TO 190678: TO TREAT OR NOT TO TREAT SHOULD NO LONGER BE THE QUESTION.[Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?].Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.Can treating the diastolic blood pressure below a certain value increase cardiovascular risk?

P2860

Q26766025-D7539EA7-0AB4-4AFF-BBCE-8B3DD36AB410 Q26824870-AE43408A-AF56-4D00-9ADF-74F7178C400D Q27023161-ACE5448F-199D-4824-ACA9-5E87250E9BB2 Q33632026-72F1E5EB-5981-4A9E-B5B4-232A30A2BF4C Q33729817-241E4B36-53B9-4B81-9A12-6F38587D11B1 Q33925329-705A71EA-AF72-4862-8C35-F3AD6DF7E8F6 Q34017371-1ADB61CD-0CF8-485B-B149-3D06B5F51C24 Q34586063-9A51FF87-809E-445E-88C5-14E92C6912FC Q34631709-C7FB0A7F-0A92-4D30-8255-4A6E8921C4D4 Q35042738-832C2084-0666-458A-853F-86AF70621039 Q35126105-CF867B2C-D343-495F-B5C3-EE6066D9DA79 Q35234551-6DE0BA82-EE87-42E9-8032-C46D3727A2BF Q35573404-A29A0E96-6B61-4721-A188-1E17A75CC97D Q35648075-29B8CC67-5A83-4D35-BF90-0D5731D7470B Q36030841-BABE0AAD-05A1-47F8-9992-370BB2D4BDD4 Q36138368-7BEC4345-F96F-4EBF-82E4-3D8FFAADB41A Q36528304-AEC0DD58-7B6A-4E74-829B-27BD017431CE Q36780930-68B2ACCD-9083-4007-AB92-E186B2839EA3 Q36791014-F6348034-8346-4ECC-9CB5-14E30E72A9E6 Q37251490-B9889F36-1A49-42AB-968A-82C6881C8A49 Q37556383-D94525B6-EAE0-4A45-987F-956C5E89B694 Q37656167-7ED70158-4AA4-4C7D-BA68-097F68055DD6 Q37703838-ED9CD3C8-0F65-48E1-A6DA-5DD1D4D4E8C3 Q37925640-FB1753DF-BC22-4C52-81D7-98136263E2C8 Q37948516-D781E3A0-D881-4C39-A396-1737C7814EB6 Q37949514-D84924F6-DF9D-4FE4-816B-C860AFC4F403 Q37970123-2A6C384F-85A9-422D-99EE-6BC07836CC75 Q37992171-BB738235-0C36-49C0-B5A8-D755BA1B0E1E Q38022713-33F6EE32-D10D-4C4F-97AD-FB0C24B2511E Q38113244-6A8C8AB3-FFB1-4AB5-A9D4-1FA074B83758 Q38130636-7F755A5A-E31C-4CB3-B2A7-C0B617765429 Q38154228-955DE160-B798-4180-8A03-A39C482480F2 Q38357890-6613206B-5C00-425E-94B7-33BDC1EF5547 Q38380852-0ABF47C4-8C3C-4053-B24B-F018B8C8B7FF Q40052463-3D7EA95D-0787-4FA3-AC5C-78D484FF3887 Q42629956-45CC7F1E-0142-4F6E-A3D5-F1382B7B28BB Q42768891-59311AF0-FC00-4C99-9348-A18E79463780 Q43981382-B1907DF2-ED47-42F2-A9B4-5E196754E06C Q44662560-3767F287-E1A8-4BAB-8940-EFC54B613263 Q46033207-289DBE12-0164-4079-B67E-E55555D8269C

P2860

Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.

http://www.wikidata.org/entity/Q30619473

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antihypertensive treatment and ...... hypertension: a meta-analysis.

@ast

Antihypertensive treatment and ...... hypertension: a meta-analysis.

@en

type

label

Antihypertensive treatment and ...... hypertension: a meta-analysis.

@ast

Antihypertensive treatment and ...... hypertension: a meta-analysis.

@en

prefLabel

Antihypertensive treatment and ...... hypertension: a meta-analysis.

@ast

Antihypertensive treatment and ...... hypertension: a meta-analysis.

@en

P1433

Q30619473-3D821FDA-2DBC-4AA5-93ED-1A53C101B9F5

P1476

Q30619473-C8D94990-2FD5-45EA-B05F-AA0A7E2AF006

P2093

Q30619473-147471DD-EBC9-486A-9597-2404067EFC0D

Q30619473-383CD776-9117-4F98-8AB0-7EA03B228A37

Q30619473-6BBD8C35-5EAB-4A2C-963B-64F6E8E91BFA

Q30619473-769FC9CB-7C64-49EC-9BFE-0CFFD13678DC

Q30619473-86DC1DB9-7034-47E8-B627-D20A779769B3

Q30619473-A48F5CEC-03CE-41D8-9C6F-414B235CBF79

P2860

Q30619473-0592E519-6331-49B9-89FE-66D308C8C5A8

Q30619473-06D6EF90-539A-45DA-B0FD-B03860166498

Q30619473-073A7E65-F365-44A3-B6AE-FCF523C815F5

Q30619473-0B78614B-75DF-4E03-8112-CB12EC4FBE04

Q30619473-1171BCE5-5112-4E77-9D8B-9D04ECE3062C

Q30619473-1175CE19-2AD6-411C-B7B0-4B22AF6E644A

Q30619473-23BE17A7-D713-4185-863A-B3E683C4E122

Q30619473-265E9B43-B9C8-43FA-9EFD-14425E5B04CF

Q30619473-274AC627-E692-4804-A263-718D6AF29F77

Q30619473-2AE7D4F1-2C11-4D4D-80C3-3C85B7DAD4EF

P304

Q30619473-719CDAA6-C962-4E1D-BAD1-2CADE5D02944

P31

Q30619473-C6371CA5-B705-41F1-BB67-1D4A64845FA0

Q30619473-FD76DD4F-71A7-484B-9D89-F9B5CA89AD5F

P356

Q30619473-F72F98AF-3156-4CBE-95CD-6D404D09F878

P407

Q30619473-BCE748B0-B333-46C2-8CF3-E5A9A7969004

P433

Q30619473-18976737-DE5C-48EB-80CE-D28AECF607C3

P478

Q30619473-7383FDCB-0506-438C-B617-02167B7DC74E

P577

Q30619473-F1863232-F7AC-46F2-A3EA-2BED27653627

P5875

Q30619473-F1BB4FF6-E0F1-4A6A-B08F-6A2B63434617

P698

Q30619473-0A290FDF-70A9-4774-B819-C542557EBDAA

P921

Q30619473-498DC5B3-9977-4797-A0DF-BF4F75292FC0

Q30619473-F67D426D-CCAB-4E10-8C81-40976F423D5A

P932

Q30619473-F6D58244-56F4-4E7A-9AEC-6F64F0452F74

P356

P1433

Journal of the American Medical Association

P1476

Antihypertensive treatment and ...... hypertension: a meta-analysis.

@en

P2093

Angela M Thompson

http://www.w3.org/2001/XMLSchema#string

Carrie L Eshelbrenner

http://www.w3.org/2001/XMLSchema#string

Jiang He

http://www.w3.org/2001/XMLSchema#string

Kristi Reynolds

http://www.w3.org/2001/XMLSchema#string

Lydia A Bazzano

http://www.w3.org/2001/XMLSchema#string

Tian Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Bias in meta-analysis detected by a simple, graphical test

Operating characteristics of a rank correlation test for publication bias

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patient

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

P304

913-922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.250

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50250087

http://www.w3.org/2001/XMLSchema#string

P698

21364140

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

arterial hypertension

P932

4313888

http://www.w3.org/2001/XMLSchema#string